APSR2026-255

Yes
Late-Breaking
Submitted
Poster Presentation
 
AP07-002
P52
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1211848-46904-APSR Poster Castleman final for submission_432760.pdf
Format: PDF Only
03. Clinical Allergy and Immunology
6

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

hemalatha Munusamy * Hospital Melaka Respiratory Melaka Malaysia
Khai Lip Ng - Hospital Melaka Respiratory Melaka Malaysia
Nur Husna Mohd Aminudin - Hospital Melaka Respiratory Melaka Malaysia
Kasuma Mohd Nordin - Hospital Melaka Respiratory Melaka Malaysia
Thilakavathiny Muniapan - Hospital Melaka Rheumatology Melaka Malaysia
Sue Anida Azman - Hospital Sultan Idris Shah Serdang Pathology Selangor Malaysia
 
 
 
 
 
 
 
 
 
Presenting Author Details
hemalatha
Munusamy
drhemalatha@hsi.gov.my
+60149386828
41-50
Malaysia
Case Report
A Young Lady with Castleman Disease: Diagnostic Challenges and Clinical Course
Maximum 25 words
Abstract Content
 
 
 
 
Castleman disease (CD) is a rare, heterogeneous lymphoproliferative disorder characterized by abnormal lymph node hyperplasia and systemic inflammation [1–5]. It is classified as unicentric (UCD), affecting a single lymph node, or multicentric (MCD), involving multiple nodes with systemic symptoms [2,3]. Dysregulated cytokine signaling, particularly interleukin-6, drives inflammation, and MCD may be associated with HHV-8 infection [2,3,4]. Histologically, CD is categorized into hyaline vascular, plasma cell, and mixed variants, with the plasma cell type showing polyclonal hypergammaglobulinemia, elevated IgG/IgG4, and interfollicular plasma cell infiltration [1–3]. Early diagnosis is crucial as UCD is surgically curable, whereas MCD requires systemic therapy [3,4].
A 40-year-old female presented with vague arthralgia and numbness. Laboratory tests showed persistently elevated ESR and CRP, positive ANA, and elevated serum IgG, with negative infectious and autoimmune workup. Imaging revealed a right paratracheal lymph node, mild inguinal lymphadenopathy, and small pulmonary nodules. Endobronchial biopsy showed a polyclonal lymphoid population with plasma cell predominance, and IgG4 was markedly elevated. Mediastinoscopic excisional biopsy demonstrated hyperplastic follicles, interfollicular plasma cell infiltration, hyalinized vessels, and fibrosis, confirming unicentric Castleman disease. Surgical excision was offered, but the patient opted for close rheumatology follow-up instead.
Castleman disease (CD) is a rare lymphoproliferative disorder with heterogeneous clinical and pathological subtypes, classified as unicentric (UCD) or multicentric (MCD) [1,6,9]. UCD usually involves a single lymph node and may be asymptomatic, whereas MCD presents with generalized lymphadenopathy, systemic inflammation, and laboratory abnormalities [6,8]. Dysregulated interleukin-6 signaling and HHV-8 infection contribute to pathogenesis [7,9]. Histologically, hyaline vascular, plasma cell, and mixed variants are recognized, with plasma cell type showing interfollicular plasma cell infiltration and polyclonal hypergammaglobulinemia [2,12,13]. Diagnosis requires imaging and biopsy, with surgical excision curative in UCD, while MCD often requires systemic therapy [3,6,8].
 
 
Yes
No
 
JPG or JPEG or PNG format ONLY
Castleman disease, histopathological, Lymphadenopathy
maximum 3 keywords and no abbreviations, separated by commas
no disclosure
300